Ovarian cancer patients can benefit from personalised vaccine, adoptive T cell therapy: Study

Combining the personalised cancer vaccine with adoptive T cell therapy (ACT) can benefit patients with late-stage, drug-resistant ovarian cancer, a new study has said.According to the study published in Nature Cancer journal, combining the ...

Related Keywords

New York ,United States ,George Coukos ,Sara Bobisse ,Lana Kandalaft , ,Nature Cancer ,